{"log_id": 1584514969188162887, "direction": 0, "words_result_num": 9, "words_result": [{"probability": {"variance": 6.3e-05, "average": 0.99586, "min": 0.964453}, "location": {"width": 829, "top": 172, "height": 51, "left": 189}, "words": "在大鼠和兔的器官发育期,大鼠口服给予最高达250mgkg剂量的西格列汀或兔"}, {"probability": {"variance": 3.4e-05, "average": 0.996511, "min": 0.976757}, "location": {"width": 827, "top": 220, "height": 52, "left": 192}, "words": "子口服给予最高达125mgkg剂量(最高为32和22倍的人体暴露量,按成人日"}, {"probability": {"variance": 0.002194, "average": 0.98968, "min": 0.709623}, "location": {"width": 829, "top": 269, "height": 50, "left": 190}, "words": "推荐剂量100mg/天计)的西格列汀都不会产生致畸作用。当大鼠口服西格列汀"}, {"probability": {"variance": 0.000136, "average": 0.994498, "min": 0.940219}, "location": {"width": 828, "top": 319, "height": 48, "left": 192}, "words": "达到1000mg/kg天(大约为人体暴露量的100倍,按成人日推荐剂量为100mg"}, {"probability": {"variance": 3.4e-05, "average": 0.996362, "min": 0.972693}, "location": {"width": 830, "top": 365, "height": 48, "left": 197}, "words": "天计)时,其后代出现与治疗相关的胎儿肋骨畸形(缺失、发育不全和波形肋骨)"}, {"probability": {"variance": 0.000379, "average": 0.991287, "min": 0.895308}, "location": {"width": 828, "top": 414, "height": 45, "left": 194}, "words": "的发生率会略有升高。无反应剂量水平为250mg/kg/天(大约为人体暴露量的32"}, {"probability": {"variance": 0.005017, "average": 0.967234, "min": 0.652669}, "location": {"width": 829, "top": 460, "height": 49, "left": 196}, "words": "倍,按成人日推荐剂量为100mg天计)。当大鼠口服西格列汀达到1000mgkg"}, {"probability": {"variance": 0.000572, "average": 0.992795, "min": 0.873064}, "location": {"width": 826, "top": 508, "height": 46, "left": 199}, "words": "天时,可观察到治疗相关的后代雄、雌鼠断奶前平均体重下降和后代雄鼠断奶后"}, {"probability": {"variance": 1e-06, "average": 0.998818, "min": 0.997239}, "location": {"width": 98, "top": 570, "height": 28, "left": 199}, "words": "体重增加"}], "language": 3}